...
首页> 外文期刊>Biotechnology Progress >Removal of Intact β2-Microglobulin at Neutral pH by Using Seed-Conjugated Polymer Beads Prepared with β2-MicroglobuIin-Derived Peptide (58-67)
【24h】

Removal of Intact β2-Microglobulin at Neutral pH by Using Seed-Conjugated Polymer Beads Prepared with β2-MicroglobuIin-Derived Peptide (58-67)

机译:通过使用β2-微球蛋白衍生肽制备的种子缀合的聚合物珠粒在中性pH下去除完整的β2-微球蛋白(58-67)

获取原文
获取原文并翻译 | 示例
           

摘要

Removal of β-microglobulin (β2M) from the blood of patients suffering from kidney dysfunction is crucial to protect those individuals from getting the diseased state of dialysisrelated amyloidosis. By harnessing the nucleation-dependent fibrillation process of amyloidogenesis, a fS2M removal strategy has been proposed by preparing seed-conjugated polymer beads and assimilating soluble β2M to the fibrils on the surface at neutral pH. A novel peptide segment of β2M ranging from residue 58 to residue 67 (Lys-Asp-Trp-Ser-Phe-Tyr-Leu-Leu-Tyr-Tyr), which was capable of being fibrillated at neutral pH was isolated. Charge interaction between the positive N-terminal lysine and the negative C-terminal α-carboxylic group was demonstrated to be critical for the molecular self-assembly leading to the peptide fibril formation by favoring β-sheet conformation: Because the peptide fibrils were successful to seed intact β2M at neutral pH, the fibrils were immobilized on polymer beads of HiCore resins, and the resulting seed-conjugated beads were used to accrete intact β2M in the form of fibrils elongated on the bead surface. Its efficiency of the β2M removal was improved by placing the seed-immobilized beads in the middle of a continuous flow of the βM-containing solution as practiced in the blood circulation during the hemodialysis. Therefore, this β2M removal system is suggested to exhibit high specificity, high binding capacity, and cost-effectiveness appropriate for eventual clinical application to remove β2M from the blood of renal failure patients.
机译:从患有肾功能不全的患者的血液中去除β-微球蛋白(β2M)对于保护这些个体免于患上与透析相关的淀粉样变性病的病情至关重要。通过利用淀粉样蛋白生成的成核依赖性原纤化过程,提出了一种fS2M去除策略,该方法通过制备种子缀合的聚合物珠粒并将可溶性β2M与中性pH下的原纤维同化。分离了能够在中性pH下原纤化的β2M的新型肽段,其范围从残基58到残基67(Lys-Asp-Trp-Ser-Phe-Tyr-Leu-Leu-Tyr-Tyr)。 N端赖氨酸的正向和C端负的α-羧基的负电荷之间的电荷相互作用被证明对于通过促进β-折叠构象而导致肽原纤维形成的分子自组装至关重要:因为肽原纤维成功地在中性pH下将完整的β2M种子固定,将原纤维固定在HiCore树脂的聚合物小珠上,然后将所得的种子缀合小珠以在小珠表面上拉长的原纤维形式积聚完整的β2M。通过将固定有种子的珠子放在血液透析过程中血液循环中连续不断的含βM溶液的中间,可以提高去除β2M的效率。因此,建议该β2M去除系统表现出高特异性,高结合能力和成本效益,适合最终临床应用以从肾衰竭患者的血液中去除β2M。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号